BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea · Delayed Price · Currency is KRW 4,520.00
+40.00 (0.89%)
Apr 8, 2026, 3:07 PM KST
BCWORLD PHARM. Revenue
In the year 2025, BCWORLD PHARM. had annual revenue of 75.80B KRW with 1.32% growth. BCWORLD PHARM. had revenue of 20.28B in the quarter ending December 31, 2025, a decrease of -5.78%.
Revenue
75.80B
Revenue Growth
+1.32%
P/S Ratio
0.55
Revenue / Employee
270.71M
Employees
280
Market Cap
41.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.80B | 985.64M | 1.32% |
| Dec 31, 2024 | 74.81B | -296.36M | -0.39% |
| Dec 31, 2023 | 75.11B | 2.41B | 3.31% |
| Dec 31, 2022 | 72.70B | 10.62B | 17.11% |
| Dec 31, 2021 | 62.08B | 5.05B | 8.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 4.16T |
| Samsung Epis Holdings | 3.02T |
| ALTEOGEN | 215.86B |
| Aprogen Biologics | 73.23B |
| METACARE CO. | 32.82B |
| Tdspharm | 27.62B |
| HASS Corp. | 16.59B |